Pathogenesis and treatment of Raynaud's phenomenon-Reference-Cited by-同舟云学术

Pathogenesis and treatment of Raynaud's phenomenon

Published:1990-01 Issue:1 Volume:4 Page:45-51
ISSN:0920-3206
Container-title:Cardiovascular Drugs and Therapy
language:en
Short-container-title:Cardiovasc Drug Ther

Author:

Coffman Jay D.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF00053426.pdf

Reference60 articles.

1. Coffman JD, Cohen RA. Role of alpha-adrenoceptor subtypes mediating sympathetic vasoconstriction in human digits. Eur J Clin Invest 1988;18:309?313.

2. Coffman JD, Cohen AS. Total and capillary fingertip blood flow in Raynaud's phenomenon. N Engl J Med 1971; 285:259?263.

3. Halpern A, Kuhn P, Shaftel HE, et al. Raynaud's disease, Raynaud's phenomenon, and serotonin. Angiology 1960; 11:151?167.

4. Lewis T. Experiments relating to the peripheral mechanism involved in spasmodic arrest of the circulation in the fingers, a variety of Raynaud's disease. Heart 1929;15:7?101.

5. Keenan EJ, Porter JM. 50?1 receptors in platelets from patients with Raynaud's syndrome. Surgery 1983;94: 204?209.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Part II: The Treatment of Primary and Secondary Raynaud’s Phenomenon;Journal of the American Academy of Dermatology;2022-07

2. Raynaud’s phenomenon and related vasospastic disorders;Vascular Medicine;2021-02

3. Partial agonist activity of α1-adrenergic receptor antagonists for chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3;PLOS ONE;2018-09-24

4. The effects of diosmin and hesperidin on capillary blood flow of upper limbs in patients with secondary Raynaud’s syndrome;Khirurgiya. Zhurnal im. N.I. Pirogova;2017

5. Guillain-Barré syndrome presenting with Raynaud's phenomenon: a case report;BMC Neurology;2014-09-03